Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000919574-15-007757
Filing Date
2015-11-13
Accepted
2015-11-12 18:10:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 d6892061_13d-a.htm SC 13D/A 204776
  Complete submission text file 0000919574-15-007757.txt   206110
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Subject) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82674 | Film No.: 151226259
SIC: 2834 Pharmaceutical Preparations

Mailing Address 731 ALEXANDER ROAD BUILDING 2 PRINCETON NJ 08540
Business Address 731 ALEXANDER ROAD BUILDING 2 PRINCETON NJ 08540 609-419-1800
CxSynta LLC (Filed by) CIK: 0001388171 (see all company filings)

EIN.: 020604347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A